BFS
HAE icon

Bare Financial Services’s Haemonetics HAE Stock Holding History

Bare Financial Services’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$750 Hold
10
– – ﹤0.01% 1503
2026
Q1 		$564 Sell
10
-39
-80% -$2.54K ﹤0.01% 1466
2025
Q4 		$3.93K Buy
49
+35
+250% +$2.35K ﹤0.01% 623
2025
Q3 		$682 Hold
14
– – ﹤0.01% 1139
2025
Q2 		$1.04K Buy
+14
New +$927 ﹤0.01% 910

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bare Financial Services's HAE Position: Q2 2026 in Review

Bare Financial Services held its Haemonetics (HAE) position steady in Q2 2026 at 10 shares worth $750. The position accounts for ﹤0.01% of the portfolio, ranked #1503.

Bare Financial Services first reported a position in HAE in Q2 2025 and has held it in 5 quarters since. The position peaked at $3.93K in Q4 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Bare Financial Services held 10 shares of Haemonetics worth $750 as of Q2 2026.
  • Bare Financial Services left its Haemonetics share count unchanged in Q2 2026.
  • Haemonetics made up ﹤0.01% of Bare Financial Services's portfolio in Q2 2026, its #1503 holding.
  • Bare Financial Services first reported a position in Haemonetics in Q2 2025 and has held it in 5 quarters since.
  • Bare Financial Services's Haemonetics position peaked at $3.93K in Q4 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.